Registrar eNom to screen bogus drug sellers

In a victory for the fight against criminal networks distributing counterfeit and adulterated drugs over the internet, the Financial Times is reporting that eNom, the world’s second-biggest registry, is to begin screening customers for unapproved drug sales.The report notes that under pressure from security professionals, ICANN and the White House, eNom “last week quietly retained LegitScript, a company that vets internet pharmaceutical concerns to make sure they are licensed to do business in the US.”To read this report in The Financial Times in full, see:

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.